Decreased expression of MAP-2 and GAD in the brain of cats infected with Feline immunodeficiency virus

Tohoku Journal of Experimental Medicine

Volumn 195, Issue 3, 2001, Pages 141-151

  Koirala, Tirtha Raj ^a   Nakagaki, Keiko ^a   Ishida, Takuo ^a   Nonaka, Shuko ^a   Morikawa, Satoko ^a   Tabira, Takeshi ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

AIDS; FIV; Glutamic acid decarboxylase; HIV 1; Microtubule associated protein

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT PROTEIN; PROTEIN ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; VIRUS INFECTION;

ANIMALS; BRAIN; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; REFERENCE VALUES;

EID: 0035569276     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.195.141     Document Type: Article

References (54)

1. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat
2. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
3. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease
4. Neuropathogenesis of AIDS
5. Molecular properties of feline immunodeficiency virus (FIV)
6. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders
7. Gamma-Aminobutyric acid (GABA) in human cerebrospinal fluid: Radioreceptor assay
8. Activation of NMDA receptor mediates the toxicity of ammonia and the effects of ammonia on the microtubule-associated protein MAP-2
9. Down's syndrome and Alzheimer's disease: Dendritic spine counts in the hippocampus
10. Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin
11. Macrophages/microglia and the pathophysiology of CNS injuries in AIDS
12. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes
13. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain
14. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy
15. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation
16. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system
17. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
18. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates
19. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases
20. Scrapie infection diminishes spines and increases varicosities of dendrites in hamsters: A quantitative Golgi analysis
21. Dendritic and synaptic pathology in mental retardation
22. Cortical neuronal cytoskeletal changes associated with FIV infection
23. Dendritic pathology: An overview of Golgi studies in man
24. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome
25. Differential response of microtubule-associated protein 2 (MAP-2) in rat hippocampus after exposure to trimethyltin (TMT): An immunocytochemical study
26. Involvement of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta)
27. Modifications in number and morphology of dendritic spines resulting from chronic ethanol consumption and withdrawal: A Golgi study in the mouse anterior and posterior hippocampus
28. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
29. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists
30. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists
31. Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands
32. Evidence for impaired GABAergic activity in the substantia nigra of amygdaloid kindled rats
33. Spectrum of human immunodeficiency virus-associated neocortical damage
34. Cortical dendritic pathology in human immunodeficiency virus encephalitis
35. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease
36. Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis
37. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain
38. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
39. Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus
40. Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus
41. Neocortical dendritic pathology in human partial epilepsy: A quantitative Golgi study
42. Neocortical pathology in chronic murine retroviral encephalitis
43. Rapid alterations in dendrite morphology during sublethal hypoxia or glutamate receptor activation
44. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome
45. Neurological abnormalities associated with feline immunodeficiency virus infection
46. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection
47. Neuropathology in cats experimentally infected with feline immunodeficiency virus: A morphological, immunocytochemical and morphometric study
48. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system
49. Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys
50. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia
51. Neurofilaments: Structure, metabolism and implications in disease
52. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1
53. Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia
54. Stability of synaptosomal GABA levels and their use in determining the in vivo effects of drugs: Convulsant agents